Power Law company profile

Voyager Therapeutics

Biotech & Life Sciences · Cambridge, United States · Founded 2014 · IPO 2015 Thoroughbred

Gene therapies for neurological diseases crossing blood-brain barrier.

Valuation

$65M

Market cap · May/2026

Revenue

$40M

Latest reported FY

Featured in $10B+ revenueThoroughbred · Power Law outcome

Investors

7 investors on Voyager Therapeutics's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 1 investor entered at this stage

Third Rock Ventures

Series B+ 6 investors entered at this stage

Brookside Capital

PFM Health Sciences

Casdin Capital

Foresite Capital

Fidelity Investments

Wellington Management

Global footprint

Where Voyager Therapeutics has talent and traffic

AI talent share

3.0% of workforce is AI talent
(5 of 168 staff)

Core AI10.6%

Other AI42.38%

Non-AI workforce16397.02%

Workforce by country

2 countries with
team presence

🇺🇸 United States99.3%

🇲🇽 Mexico0.7%

2 countries shown

Web traffic by country

7.5K monthly visits
across markets

🇺🇸 United States77.3%

🇮🇳 India12%

🇫🇷 France8%

🏳️ Korea2.7%

🏳️ Republic of0%

Top 5 markets shown

Market sentiment

What the market is saying about Voyager Therapeutics

An AI-synthesized read of the highest-engagement posts about Voyager Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Voyager Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles